Launch your Graphy
There are no items in your cart
Add More
Add More
| Item Details | Price | ||
|---|---|---|---|
Regulatory Studio at SwaLife: Building AYUSH, FSSAI, CDSCO, FDA-Compliant Herbal Products
access_time 2026-01-21T04:39:39.093Z face Shruti Joshi
Regulatory Studio at SwaLife: Building AYUSH, FSSAI, CDSCO, FDA-Compliant Herbal Products SwaLife Consultancy 21.1.26 At SwaLife, regulatory strategy is not treated as a checklist at the end of development. It is engineered as a data-driven, AI-enabled studio that runs in parallel with discovery, de...
Why Drug Discovery Takes 10–15 Years: The Reality Behind the Timeline
lock Member-only
access_time
2026-01-20T05:56:55.894Z
face Shruti Joshi
Why Drug Discovery Takes 10–15 Years: The Reality Behind the Timeline Swalife Academy 20.1.26 One of the most common questions in modern medicine is deceptively simple: In an age of artificial intelligence, high-throughput laboratories, and billion-dollar research budgets, a decade-long timeline can...
EFSA’s Use of Observational Data for Food Supplement Health Claims
access_time 2026-01-20T05:55:09.33Z face Shruti Joshi
EFSA’s Use of Observational Data for Food Supplement Health Claims SSTSI 20.1.26 Health claims on food supplements carry significant scientific and regulatory responsibility. In the European Union, such claims must be supported by robust evidence demonstrating a clear relationship between the ingred...
MHRA Observational Evidence in Post-Brexit Herbal Approvals
access_time 2026-01-20T05:53:40.531Z face Shruti Joshi
MHRA Observational Evidence in Post-Brexit Herbal Approvals SSTSI 20.1.26 The regulatory landscape for herbal products in the United Kingdom has undergone a significant transformation following Brexit. With the UK no longer operating under the European Medicines Agency framework, the responsibility ...
Mapping Herbal Trials on WHO-ICTRP and ClinicalTrials.gov
access_time 2026-01-20T05:50:26.778Z face Shruti Joshi
Mapping Herbal Trials on WHO-ICTRP and ClinicalTrials.gov SSTSI 20.1.26 Herbal medicine is steadily moving from traditional knowledge systems into evidence-based global healthcare. As botanical products, plant-derived compounds, and multi-herb formulations enter formal clinical evaluation, the abili...